Patent ID: 11878076
Assignee: NIVAGEN PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 6:
7. A pharmaceutical product, comprising:
a single use dose vial, and
a composition comprising a 65 mg dose, a 100 mg dose, a 130 mg dose, or a 200 mg dose of phenobarbital sodium, in the single use dose vial,
wherein the composition is sterile and lyophilized,
wherein the composition comprises no less than 98% phenobarbital sodium, and
wherein the composition has the property that when the composition is stored at room temperature for 6 months and then reconstituted for injection with 10 mL of an aqueous solution to form a reconstituted composition, the reconstituted composition contains no more than 0.1% phenylethylacetylurea (PEAU).